HMGB1 and cancer: To study the functional consequences of TLR2 in HMGB1 mediating CD133− cancer cells dedifferentiation, TLR2 was inhibited by shRNA technology or used the TLR2 inhibitor (Stevioside) in the CD133− cancer cell coculture system.